Introduction to ArtificiaI Intelligence in Higher Education
Placebo and nocebo
1. Click to edit Master title style
1
PLACEBO And NOCEBO
Dr. Ashishkumar Baheti
MD Pharmacology
2. Click to edit Master title style
2
Definition
• Dummy medicine containing no active
substance
• Latin: 'I shall please‘
• Psychodynamic >Pharmacodynamic
• Patients who respond to placebo are termed
as “Placebo responders”
3. Click to edit Master title style
3
• 1811 : Quincy's Lexicon-Medicum defines
placebo as 'an epithet given to any medicine
adapted more to please than to benefit the
patient
• 1960s:( Shapiro) States that any therapeutic
procedure which has an effect on a patient,
symptom, syndrome or disease, but which is
objectively without specific activity for the
condition being treated.
History
4. Click to edit Master title style
4
• In 1801, John Haygarth reported the results
of what may have been the first placebo
controlled trial
• 1930: . Evans and Hoyle with colleagues
actually used the word placebo for the inert
treatment given to controls in an
experimental situation.
5. Click to edit Master title style
5
• In 1863, Austin Flint tried to understand
whether drugs given for articular
rheumatism changed the natural history of
disease
Flint placed 13 patients on the use of a
placebo which consisted the tincture of
quassia, very largely diluted. Became well
known placeboic remedy for rheumatism
6. Click to edit Master title style
6
Incidence
• 15 studies, carried out by Beecher (1955)
involving 1082 patients, the average
placebo response rate determined was
35.2%.
•When the patients do not know they are
receiving placebos, rate high as 70-82%
7. Click to edit Master title style
7
• Back surgery : suggested by Spangfort’s
review of long-term outcomes of 2504
“dissectomies” for lumbar disk disease.
• Complete relief of back pain was noted in
43% of patients who had sham surgery
done.
8. Click to edit Master title style
8
Placebo effect
• Shapiro (1959): the psychological,
physiological or psycho-physiological effect
of any medication or procedure and which
operates through a psychological
mechanism .
• a change in a patients illness attributable to
the symbolic import of a treatment rather
than a specific pharmacologic or
physiologic property.
9. Click to edit Master title style
9
Types
Positive Negative
Improvement
in symptoms
Symptoms
Getting
worse
10. Click to edit Master title style
10
Hawthorne effect
• 1930s -Phenomenon whereby a subject’s
performance changes simply because he or
she is being studied.
11. Click to edit Master title style
11
Nocebo
• latin: nocero (inflicting harm)
• Opposite of placebo
• Negative psychodynamic effect evoked by the
pessimistic attitude of the patient, or loss of
faith in medication/physician
• T
o induce a nocebo effect, an inert substance is
administered along with negative verbal
suggestions of clinical worsening.
• Mediated by receptors like CCK1 & NK1.
12. Click to edit Master title style
12
• Colloca et al (2008) used a nocebo
procedure, in which verbal suggestions of
painful stimulation were given to healthy
volunteers before administration of either
tactile or low-intensity painful electrical
stimuli.
• This study showed that these anxiogenic
verbal suggestions were capable of turning
tactile stimuli into pain, as well as low-
intensity painful stimuli into high-intensity
pain.
13. Click to edit Master title style
13
Types of placebo
• Inert or Pure placebos : substances that
could have no conceivable pharmacologic
effect on the patient.
Examples : Dummy pills or capsules
containing lactose or chalk
14. Click to edit Master title style
14
Active or Impure placebo :
Have potential pharmacological effects, though
not necessarily any specific activity for the
condition under treatment.
Examples : vitamin B12 or iron in the absence
of anemia,Antibiotics in viral infections
15. Click to edit Master title style
15
Inert substances used
• Inert pills, drugs, or
saline injections
• Sham surgeries
• Inactive medical
devices
• Injections of distilled
water
16. Click to edit Master title style
16
MECHANISM OF ACTION
Conditioning
reflex model
Opioid
model
Expectancy
model
17. Click to edit Master title style
17
Conditioning reflex model
• Involuntary conditioned reflex of the patient’s
body
• Arachnoiditis pain ,were relieved after
they received intrathecal injections of
procain.
. But actually injected with saline rather
than procaine
18. Click to edit Master title style
18
Other Conditions Are
• Presence Of Physician
• physical examination
• prescription
• Procedure
19. Click to edit Master title style
19
Expectancy model
Aimed at preparing the body to anticipate an
event to better cope with it
For example, resuming a normal daily
schedule, and negative expectations leading
to its inhibition
Effects of expectations modulated by
-Decrease in self-defeating thoughts.
-Motivation
20. Click to edit Master title style
20
Expectation of Reward
Expectations of future events modulate not
only anxiety, but they may also induce
physiological changes through reward
mechanisms.
• These mechanisms are mediated by specific
neuronal circuits linking cognitive, emotional, and
motor responses.
21. Click to edit Master title style
21
Opioid model
• Release of endogenous opiate :
endorphins & enkephalins
• Field et all (1997) shown that placebo
induced analgesia can be reversed by
naloxone
22. Click to edit Master title style
22
FACTORS
INFLUENCING
PLACEBO
RESPONSE
Patient characteristics
Provider
characteristics
Appearance of
treatment
procedures
Environment
relationship
23. Click to edit Master title style
23
Application in clinical trials
• Researcher compares the results of
experimental treatment versus placebo.
• The placebo-controlled trial is the gold
standard for testing the efficacy of new
treatments.”
• Best evidence for new treatment come from
randomized placebo- controlled (RCT)
double-blind studies.
24. Click to edit Master title style
24
• placebo is used in clinical drug trials
for the following reasons:
1. Compare effects with those of the active
drug
2. Comparison of active drugs validated by a
placebo
3. Blind administration of two drugs that
cannot be made indistinguishable (Double
Dummy technique)
25. Click to edit Master title style
25
4. Wihdrawal period
5. Toxicity
26. Click to edit Master title style
26
Ethics
Topic of debate
• Ethical : use of placebos is essential to
protect the society from the harm that could
result from the widespread use of ineffective
medical treatments.
• Unethical: Alternative study designs would
produce similar results with less risk to
individual research participants.
27. Click to edit Master title style
27
• Declaration of Helsinki:
“In any medical study, every patient
including those of control group, should be
assured of the best proven diagnostic and
therapeutic methods and no patient should
suffer from unnecessary pain.”
28. Click to edit Master title style
28
CONTROVERSY
• Observed response to placebo in RCT may
reflect the
1. natural course of the disease
2. fluctuations in symptoms
3. regression to the mean
4 . response bias with respect to the
patient's reporting of subjective
symptoms and other concurrent
treatments
29. Click to edit Master title style
29
Clinical equipoise in placebo-controlled
trials
state where clinicians are unsure whether the
new treatment or intervention is as good as
the standard treatment.
Violation of the therapeutic obligation
of physicians to offer optimal medical
care.
right of the patient to receive the best care
possible is compromised .
30. Click to edit Master title style
30
Human research protection guidelines
• The Office for Human Research Protection
(OHRP) published guidelines in 2008 for the
use of placebo
• “Placebos may be used in clinical trials where
there is no known or available (i.e., FDA-
approved) alternative therapy that can be
tolerated by subjects.”
31. Click to edit Master title style
31
The use of placebos in controlled clinical
trials must be justified by a positive risk-
benefit analysis
The subjects must be fully informed of the
risks involved in the assignment to the
placebo group.
Continued assignment of subjects to
placebo is unethical, once there is good
evidence to support the efficacy of the
trial therapy.
32. Click to edit Master title style
32
Subjects with an increased risk of harm from
non- response may be excluded.
Increased monitoring for deterioration of
subjects and the use of rescue medications may
be included in the protocol.
‘Early escape’ mechanisms and explicit withdrawal
criteria may be built in so that subjects will not
undergo prolonged placebo treatment if they are
not doing well.
• The size of the population placed on placebo
may be kept smaller than the number in the
active treatment arms.
33. Click to edit Master title style
33
• Some drug trials involve a period during
which all participants receive only a
placebo prior to the initiation of the study.
This period is called a ‘placebo washout’.
---The purposes of a washout period include:
1. Terminating the effects of any drug the
subject may have been taking before
entering the clinical trial, so that the effects
of the trial drug may be observed.
34. Click to edit Master title style
34
2.Understanding whether the subjects co
operate with instructions to take drugs.
3.Understanding which subjects are ‘placebo
responders’, in that they experience a high
degree of placebo effect.
4. In some protocols, the investigators
plan to exclude those subjects they find
either poorly compliant or highly
responsive to the placebo
35. Click to edit Master title style
35
• The informed consent information:
1. The subjects must be informed that they
may be given a placebo.
2. A clear lay definition of the term ‘placebo’
must be given to the subjects.
3. The rationale for using a placebo
must be explained to the subjects.
.
36. Click to edit Master title style
36
4. If applicable, the subjects must be informed
of any viable medical alternatives to being
placed on placebo.
5. The duration of time that a subject will be on
a placebo, degree of discomfort, and
potential effects of not receiving active
medication must all be explained.
6. Any consequences of delayed active
treatment must be explained to the subjects
37. Click to edit Master title style
37
7. A statement in the risk section of
the consent that, the condition of
the subject may worsen while on
placebo should be included.
8. A discussion in the benefits section that,
subjects who receive placebo will not receive
the same benefit as those who receive active
treatment ,if that treatment is effective should
also be included.
38. Click to edit Master title style
38
Problems assosciated with placebo
1. Imperfect likeness
2. Impure placebos
3. Selecting placebo non-reactors
4. Overestimation of placebo effects
Quassia is a plant. The wood is used as medicine. Quassia is used for treating an eating disorder called anorexia, indigestion, constipation, and fever. It is also used to rid the intestines of various kinds of worms; as a tonic or purgative; and as a mouthwash. Some people apply quassia directly to the scalp for lice.
Sham surgery (placebo surgery) is a faked surgical intervention that omits the step thought to be therapeutically necessary. In clinical trials of surgical interventions, sham surgery is an important scientific control